Prediction of gestational diabetes mellitus based on an analysis of amniotic fluid by capillary electrophoresis.
To detect gestational diabetes mellitus biomarkers in human amniotic fluid collected for age-related genetic testing using capillary electrophoresis and a sophisticated data analysis methodology. Amniotic fluid samples were separated by capillary electrophoresis. Samples were classified using a genetic algorithm with Bayesian benefit function. The best model maximized the sensitivity and specificity and employed a leave-one-out cross-validation strategy. Gestational diabetes mellitus (GDM; n = 14) was distinguished from non-GDM (n = 95) with 86% sensitivity and 99% specificity using two wavelets. These wavelets were located in the unresolved protein region and on the edge of the maternally derived albumin peak. GDM is a maternal pathology; however, it was shown that it alters the biochemical profile of amniotic fluid. Testing for GDM is normally carried out at 24-28 weeks, but changes can be detected at 15 weeks gestation, suggesting that GDM onset occurs early in gestation.